标题
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs
作者
关键词
-
出版物
Expert Review of Clinical Immunology
Volume 10, Issue 8, Pages 1059-1067
出版商
Informa UK Limited
发表日期
2014-06-05
DOI
10.1586/1744666x.2014.924854
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunotherapy of Allergic Rhinitis: New Therapeutic Opportunities with Virus-like Particles Filled with Cpg Motifs
- (2013) Ludger Klimek et al. American Journal of Rhinology & Allergy
- Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides
- (2013) Céline Pellaton et al. Clinical and Translational Allergy
- Subcutaneous and Sublingual Immunotherapy for Allergic Rhinitis: What is the Evidence?
- (2012) Sarah K. Wise et al. American Journal of Rhinology & Allergy
- The hygiene hypothesis in allergy and asthma
- (2012) Collin Brooks et al. Current Opinion in Allergy and Clinical Immunology
- Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study
- (2012) Deepen Patel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?
- (2011) G. Senti et al. ALLERGY
- Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
- (2011) L. Klimek et al. CLINICAL AND EXPERIMENTAL ALLERGY
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- Mechanisms of allergen-specific immunotherapy
- (2011) Cezmi A. Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Allergic rhinitis: Direct and indirect costs
- (2010) Michael S. Blaiss ALLERGY AND ASTHMA PROCEEDINGS
- Efficacy and Safety of a Glutaraldehyde-Modified House Dust Mite Extract in Allergic Rhinitis
- (2010) Herbert Riechelmann et al. American Journal of Rhinology & Allergy
- Designing CD8+ T cell vaccines: it's not rocket science (yet)
- (2010) Jonathan W Yewdell CURRENT OPINION IN IMMUNOLOGY
- TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
- (2010) Sudhanshu Agrawal et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Cutting Edge: Type I IFN Reverses Human Th2 Commitment and Stability by Suppressing GATA3
- (2010) J. P. Huber et al. JOURNAL OF IMMUNOLOGY
- Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
- (2010) Daniel E. Speiser et al. JOURNAL OF IMMUNOTHERAPY
- Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
- (2009) Jörg Vollmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial
- (2009) G. Senti et al. CLINICAL AND EXPERIMENTAL ALLERGY
- TLR Cross-Talk Specifically Regulates Cytokine Production by B Cells from Chronic Inflammatory Disease Patients
- (2009) M. Jagannathan et al. JOURNAL OF IMMUNOLOGY
- Viral Sequestration of Antigen Subverts Cross Presentation to CD8+ T Cells
- (2009) Eric F. Tewalt et al. PLoS Pathogens
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
- (2008) J. Bousquet et al. ALLERGY
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma
- (2008) Maja A. Hofmann et al. JOURNAL OF IMMUNOTHERAPY
- Allergen-related approaches to immunotherapy
- (2008) Jennifer M. Rolland et al. PHARMACOLOGY & THERAPEUTICS
- Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
- (2008) G. Senti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation